[Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma]
- PMID: 2093889
[Diagnostic and therapeutic possibilities of meta-iodobenzylguanidine in neuroblastoma]
Abstract
MIBG is taken up preferentially by neuroblastoma cells. Owing to its high concentration in the neuroblastoma lesions, *I-MIBG scan is one of the most specific and effective tools in the diagnosis and staging of the disease. For most imaging purpose 123I-MIBG is the optimal agent. A rational approach 131I-MIBG has the potential for specifically delivering very large radiation doses to the malignant cells. The results obtained in more institutions are encouraging and this therapeutic modality should be included in the therapeutic strategy of neuroblastoma.
Similar articles
-
Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.Prog Clin Biol Res. 1991;366:439-45. Prog Clin Biol Res. 1991. PMID: 2068157 No abstract available.
-
Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.Nuklearmedizin. 1986 Oct;25(5):172-5. Nuklearmedizin. 1986. PMID: 3797256
-
[Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].Nuklearmedizin. 1992 Dec;31(6):209-12. Nuklearmedizin. 1992. PMID: 1491958 German.
-
Meta-iodobenzylguanidine in children.Semin Nucl Med. 1993 Jul;23(3):231-42. doi: 10.1016/s0001-2998(05)80104-7. Semin Nucl Med. 1993. PMID: 8378796 Review.
-
Nuclear medicine imaging in pediatric oncology.J Nucl Biol Med (1991). 1994 Mar;38(1):76-84. J Nucl Biol Med (1991). 1994. PMID: 8075180 Review.
Cited by
-
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Cochrane Database Syst Rev. 2015. PMID: 26417712 Free PMC article.
-
Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.Eur J Nucl Med. 1995 Apr;22(4):322-9. doi: 10.1007/BF00941848. Eur J Nucl Med. 1995. PMID: 7607262
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical